BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 2126576)

  • 1. Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
    Ruan GJ; Zanwar S; Ravindran A; Schram S; Abeykoon JP; Hazim A; Young JR; Shah MV; Bennani NN; Jiang L; Morlote D; Rech KL; Goyal G; Go RS;
    Am J Hematol; 2024 May; 99(5):871-879. PubMed ID: 38409747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An advanced case of gastric histiocytic sarcoma treated with chemotherapy and gastrectomy: a case report and review of literature.
    Matsunaga R; Kanazawa Y; Matsuno K; Kakinuma D; Tokura T; Marumo A; Yui S; Ando F; Masuda Y; Hagiwara N; Nomura T; Kato S; Yoshiyuki T; Domoto Y; Sakatani T; Ohashi R; Inokuchi K; Yoshida H
    Clin J Gastroenterol; 2021 Aug; 14(4):1053-1059. PubMed ID: 34100257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha in childhood haematological malignancies.
    Simkó R; Nagy K
    Postgrad Med J; 1996 Dec; 72(854):709-13. PubMed ID: 9015462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of true malignant histiocytosis: identification of histiocytic origin with use of immunohistochemical and immunocytogenetic methods.
    Sato T; Terui T; Kogawa K; Nagaoka Y; Sato Y; Iyama S; Takada K; Hagiwara S; Takahashi S; Oku T; Matsunaga T; Takahashi M; Kato J; Sakamaki S; Torigoe T; Sato N; Hirayama M; Niitsu Y
    Ann Hematol; 2002 May; 81(5):285-8. PubMed ID: 12029539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological effects of gamma interferon and the combination of gamma interferon and interleukin-2 after autologous bone marrow transplantation.
    Vey N; Viens P; Fossat C; Olive D; Sainty D; Baume D; Stoppa AM; Bouabdallah R; Brandely M; Gastaut JA; Maraninchi D; Blaise D
    Eur Cytokine Netw; 1997 Dec; 8(4):389-94. PubMed ID: 9459619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A patient with plaque-stage mycosis fungoides has successfully been treated with long-term administration of IFN-gamma and has been in complete remission for more than 6 years.
    Horikoshi T; Onodera H; Eguchi H; Hanada N; Fukuzawa K; Takahashi M; Ishihara K; Ikeda S
    Br J Dermatol; 1996 Jan; 134(1):130-3. PubMed ID: 8745899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of malignant histiocytosis successfully treated with combination interferon and etoposide therapy.
    Takemori H; Sakata Y; Suzuki H; Yamaya T; Furugori N; Morimoto S; Yoshida Y
    Jpn J Clin Oncol; 1990 Dec; 20(4):431-5. PubMed ID: 2126576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant histiocytosis with complex chromosomal abnormality: successful treatment with CHOP-E chemotherapy].
    Mori H; Shimizu T; Harada H; Miyoshi Y; Okada S; Takizawa Y; Niikura H; Terada H; Fujita K
    Rinsho Ketsueki; 1991 Mar; 32(3):244-9. PubMed ID: 2041166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant histiocytosis with central nervous system involvement and hepatic mucinous cystadenoma in a single patient with review of the literature.
    Colovic N; Jurisic V; Colovic M
    J BUON; 2007; 12(4):539-42. PubMed ID: 18067214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.